Plexus Corp. (PLXS)
| Market Cap | 7.13B +110.4% |
| Revenue (ttm) | 4.31B +8.6% |
| Net Income | 187.54M +31.4% |
| EPS | 6.83 +32.9% |
| Shares Out | 26.76M |
| PE Ratio | 39.01 |
| Forward PE | 29.88 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 222,432 |
| Open | 265.90 |
| Previous Close | 260.71 |
| Day's Range | 263.15 - 268.46 |
| 52-Week Range | 115.35 - 275.83 |
| Beta | 0.88 |
| Analysts | Strong Buy |
| Price Target | 222.75 (-16.43%) |
| Earnings Date | Apr 29, 2026 |
About PLXS
Plexus Corp. provides electronic manufacturing services in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services. It serves the aerospace/defense, healthcare/life sciences, and industrial/commercial sectors. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.
Financial Performance
In fiscal year 2025, Plexus's revenue was $4.03 billion, an increase of 1.82% compared to the previous year's $3.96 billion. Earnings were $172.89 million, an increase of 54.62%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for PLXS stock is "Strong Buy." The 12-month stock price target is $222.75, which is a decrease of -16.43% from the latest price.
News
Plexus price target raised to $285 from $206 at Needham
Needham analyst James Ricchiuti raised the firm’s price target on Plexus (PLXS) to $285 from $206 and keeps a Buy rating on the shares. The company reported strong Q2 results
Plexus price target raised to $280 from $250 at Stifel
Stifel raised the firm’s price target on Plexus (PLXS) to $280 from $250 and keeps a Buy rating on the shares.
Plexus price target raised to $275 from $205 at Raymond James
Raymond James raised the firm’s price target on Plexus (PLXS) to $275 from $205 and keeps an Outperform rating on the shares after “strong” Q2 results. Raymond James noted that
Plexus Earnings Call Transcript: Q2 2026
Q2 2026 saw 19% year-over-year revenue growth and record new program wins, with strong performance across all sectors. Fiscal 2026 guidance was raised to mid-teens revenue growth and robust margins, supported by operational efficiency and proactive supply chain management.
Plexus announces retirement of CFO Jermain, Abuhl to succeed
Plexus (PLXS) announced that Patrick Jermain, Executive Vice President and Chief Financial Officer, CFO, has elected to retire after a 15-plus year career at Plexus, including 12 years as CFO.
Plexus reports Q2 adjusted EPS $2.05, consensus $1.88
Reports Q2 revenue $1.164B, consensus $1.13B. Todd Kelsey, President and Chief Executive Officer, commented, “Our momentum is accelerating broadly. For the fiscal second quarter, we increased revenue ...
Plexus sees Q3 EPS $2.02-$2.18, consensus $1.99
Sees Q3 revenue $1.2B-$1.25B, consensus $1.15B
Plexus Announces Planned Chief Financial Officer Transition
NEENAH, WI, April 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today that Patrick Jermain, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after...
Plexus Announces Fiscal Second Quarter Financial Results
NEENAH, WI, April 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended April 4, 2026, and guidance for our fiscal third quarte...
Plexus upgraded to Buy from Hold at Stifel
Stifel upgraded Plexus (PLXS) to Buy from Hold with a price target of $250, up from $200. The firm believes the supply chain sector is “entering a period of simultaneous
Plexus management to meet with Benchmark
Meeting to be held in New York on March 11 at 12 pm hosted by Benchmark.
Plexus Transcript: 47th Annual Raymond James Institutional Investor Conference
The company is experiencing strong growth momentum, driven by ramping programs in healthcare, industrial, and aerospace/defense sectors. Investments in automation, AI, and global capacity expansion are improving margins and operational efficiency, while proactive supply chain management and a robust balance sheet support continued growth and shareholder returns.
Plexus Transcript: AGM 2026
The meeting covered board elections, executive compensation, and auditor ratification, all of which passed by majority vote. Fiscal 2025 featured strong financial results, sustainability achievements, and ongoing strategic investments. No shareholder questions were raised.
Plexus price target raised to $220 from $195 at Benchmark
Benchmark raised the firm’s price target on Plexus (PLXS) to $220 from $195 and keeps a Buy rating on the shares following stronger-than-expected results. While “constructive” heading into the print,
Plexus price target raised to $200 from $150 at Stifel
Stifel analyst Ruben Roy raised the firm’s price target on Plexus (PLXS) to $200 from $150 and keeps a Hold rating on the shares. Management now guides FY26 revenue to
Plexus Earnings Call Transcript: Q1 2026
Strong year-over-year revenue and EPS growth were driven by program ramps and market share gains, with robust wins in aerospace/defense and healthcare. Guidance for fiscal 2026 was raised to the high end of the 9%-12% revenue growth target, supported by operational efficiency, automation, and strong end-market demand.
Plexus reports Q1 adjusted EPS $1.78, consensus $1.73
Reports Q1 revenue $1.07B, consensus $1.07B. Todd Kelsey, president and CEO, commented, “We have achieved significant momentum from our consistent focus on delivering customer success and our ongoing ...
Plexus sees Q2 EPS $1.80-$1.95, consensus $1.76
Sees Q2 revenue $1.11B-$1.15B, consensus $1.08B. Kelsey continued, “We are forecasting accelerating sequential revenue growth for our fiscal second quarter from continued new program ramps, market sha...
Plexus Announces Fiscal First Quarter Financial Results
NEENAH, WI, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal first quarter ended January 3, 2026, and guidance for our fiscal second quart...
Plexus price target raised to $195 from $165 at Benchmark
Benchmark analyst David Williams raised the firm’s price target on Plexus (PLXS) to $195 from $165 and keeps a Buy rating on the shares ahead of the company’s scheduled fiscal
Plexus Sets Fiscal First Quarter 2026 Earnings Release Date
NEENAH, WI, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal first quarter 2026 results after market close on Wednesday, January 28, 2026. Plexu...
Evolv selects Plexus as new strategic contract manufacturing partner
Evolv (EVLV) announced it has entered into a strategic contract manufacturing partnership with Plexus (PLXS). Evolv said the new partnership helps position it to meet growing demand while enhancing vi...
Evolv Technology Selects Plexus as New Strategic Contract Manufacturing Partner
WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today ...
Plexus price target raised to $150 from $140 at Stifel
Stifel raised the firm’s price target on Plexus (PLXS) to $150 from $140 and keeps a Hold rating on the shares after sales and earnings beat consensus in what the
Plexus downgraded to Neutral from Buy at Sidoti
Sidoti analyst Anja Soderstrom downgraded Plexus (PLXS) to Neutral from Buy with a $150 price target The firm views Q4 results as “solid,” but is scaling back FY26 and FY27